Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp Exclusively Licenses Yale s Blood Test for Epithelial Ovarian Cancer

NEW YORK, Feb. 24 (GenomeWeb News) - Laboratory Corporation of America announced yesterday that it has entered into an exclusive licensing agreement with Yale University to commercialize the university's new blood testing technology for epithelial ovarian cancer.

 

Under terms of the agreement, Yale will receive signing, milestone and royalty fees.

 

The new epithelial ovarian cancer test is based on a collection of serum proteins associated with cancer biology. Each protein marker is analyzed using an ELISA assay, and a statistical analysis is then performed to score the combined results.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.